Dr. Christopher James Kandl, MD

Dr. Kandl practices at VCU Medical Center in Richmond, Virginia, part of Commonwealth of Virginia.

Dr. Kandl's NPI, 1346535846, was assigned on June 13, 2011. Dr. Kandl graduated from Medical University of South Carolina College of Medicine in 2011. Dr. Kandl holds Virginia license 0101262852.

Dr. Kandl's primary practice is VCU Medical Center, at 1250 East Marshall Street, Richmond, VA 23298 in Richmond City. The practice phone is (804) 828-9000.

Dr. Kandl's primary practice is VCU Medical Center in Richmond, Virginia, part of Commonwealth of Virginia. Dr. Kandl is also affiliated with Mary Washington Hospital. The medical group on file is MCV Physicians. Dmand AI also links Dr. Kandl to 2 more hospitals, 1 group practice or clinic and 1 urgent care center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kandl practices, 6 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Kandl's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Kandl is licensed in Virginia.

CMS data shows 428 Medicare services from Dr. Kandl across 7 procedure codes in 2024, for 193 Medicare patients. Medicare paid $37,933 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 193 Medicare patients who saw Dr. Kandl in 2024. The largest group is 65 to 74, with 101 patients. 75% of them have high cholesterol, and 70% have high blood pressure. 16% are also on Medicaid. Their average risk score is 1.96, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kandl's median patient age at 72, with 40% women.

In 2024, Dr. Kandl wrote 45 Medicare Part D claims for 30 patients. 98% of them were for generic drugs. CMS names the drug for 12 of them, across 1 drug with 11 or more claims each, at $72 in total drug cost. In 2022, CMS named 26 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Kandl for performance year 2024, reported as part of a group. Dr. Kandl accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 15 procedures of melanoma (skin cancer) excision by Dr. Kandl, more than 70% of the clinicians it reports for that procedure.

Upper gastrointestinal (GI) endoscopy for acid reflux: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 4 papers to Dr. Kandl, published from 2016 to 2022. The most frequent topics are Head and Neck Neoplasms. Dr. Kandl's most frequent co-authors are Srihari Daggumati, MD, Kiran Kakarala, MD and Pavan Suresh Krishnan, MD.

CMS Open Payments shows 12 general payments to Dr. Kandl from 5 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Stryker Corporation paid the most, $458.

Dr. Kandl graduated from Medical University of South Carolina College of Medicine in 2011.